The effects of verapamil and lidocaine on the duration of propofol and xylazine-ketamine anesthesia in broiler chickens

Veterinary and Human Toxicology

Volumn 38, Issue 3, 1996, Pages 181-183

  Roder, Joseph D ^a   Shen, Ying ^a   Sangiah, Subbiah ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; KETAMINE; LIDOCAINE; PROPOFOL; SODIUM CHANNEL; VERAPAMIL; XYLAZINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG POTENTIATION; MALE; NONHUMAN; SLEEP TIME;

AGING; ANALYSIS OF VARIANCE; ANESTHESIA; ANESTHETICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; KETAMINE; LIDOCAINE; MALE; PROPOFOL; RANDOM ALLOCATION; SLEEP; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TIME FACTORS; VERAPAMIL; XYLAZINE;

ANIMALIA; GALLUS GALLUS;

EID: 0029914279     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Saha N, Chugh Y, Sankaranarayanan A et al: Interactions of verapamil and diltiazem with ketamine: Effects on memory and sleeping time in mice. Methods Find Exp Clin Pharmacol 12: 507-511, 1990.
2. Shen Y, Sangiah S: Effects of cadmium and verapamil on ketamine-induced anesthesia in mice. Vet Human Toxicol 37: 201-203, 1995.
3. Morgan DWT, Legge K: Clinical evaluation of propofol as an intravenous anesthetic agent in cats and dogs. Vet Rec 124: 31-33, 1989.
4. Glen JB: Animal studies of the anesthetic activity of ICl 35 868. Br J Anaesth 52: 731-742, 1980.
5. Fitzgerald G, Cooper JE: Preliminary studies on the use of propofol in the domestic pigeon (Colutnba livia). Res Vet Sci 49: 334-338, 1990.
6. Mikaelian J: Intravenously administered propofol for anesthesia of the common buzzard (Buteo buteo), the tawny owl (Strix aluco), and the barn owl (Tyto alba). Proceedings of the First Conference of the European Committee of the Association of Avi - an Veterinarians, Vienna, 13-16 March 1991: 97-101, 1991.
7. Frenkel C, Urban BW: Molecular actions of racemic ketamine on human CNS sodium channels. Br J Anaesth 69: 292-297, 1992.
8. Lin LH, Chen LL, Zirrolli JA et al: General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acid A receptors expressed by Xenopus oocytes: Lack of involvement of intracellular calcium. J Pharmacol Exp Ther 263: 569-578, 1992.
9. Frenkel C, Duch DS, Urban BW: Effects of iv anesthetics on human brain sodium channels. Br J Anaesth 71: 15-24, 1993.
10. 2+ channel blocker. Anesth Analg 76: 24-32, 1993.
11. Greene SA, Thurmon JC: Xylazine - A review of its pharmacology and use in veterinary medicine. J Vet Pharmacol Ther 11: 295-313, 1988.
12. Roder JD, Akkaya R, Amouzadeh HR et al: Effects of hepatic P-450 enzyme inhibitors and inducers on the duration of xylaZine+ketamine anesthesia in broiler chickens and mice. Vet Human Toxicol 35: 116-118, 1993.
13. Frenkel C, Urban BW: Human brain sodium channels as one of the molecular target sites for the new intravenous anesthetic propofol (2,6-diisopropylphenol). Eur J Pharmacol 208: 75-79, 1991.
14. Bunting P, Ramsay TM, Pleuvry BJ: An in-vitro study of the interactions between intravenous induction agents and the calcium antagonists verapamil and nifedipine. J Pharm Pharmacol 41: 840-843, 1989.
15. Schoffstall JM, Spivey WH, Gambone LM et al: Effects of calcium channel blocker overdose-induced toxicity in the conscious dog. Ann Emerg Med 20: 1104-1108, 1991.
16. Ellenhorn MJ, Barceloux DG: Medical Toxicology: Diagnosis and Treatment of Human Poisonings. Elsevier, New York: 198-199, 1988.
17. Windholz M, Budavari S Eds: The Merck Index, 10th ed. Merck & Co Inc, Rahway, NJ: 9748, 1983.
18. el-Fawal HA, Jortner BS, Ehrich M: Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers: In vivo and in vitro electrophysiological assessment. Neurotoxicology 11: 573-592, 1990.